Description

Chemical Properties

Description

GLP-3R is a novel multi-receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously, representing a triple-action approach to metabolic research. It is studied for its ability to promote weight reduction by enhancing energy expenditure, reducing appetite, and improving insulin sensitivity. Early clinical investigations have demonstrated significant reductions in body mass and improvements in glycemic control, positioning Retatrutide as a promising compound in metabolic and obesity-related research.